Amitriptyline hydrochloride

盐酸阿米替林

Report date: 2026/04/30 20:00:20
NME

Base Information

Drug NameAmitriptyline hydrochloride
Drug Alias Nameamitriptylinum阿密曲替林盐酸阿密替林amitriptilina依拉维 +[19] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine reuptake inhibitor
TargetsMonoamine transporters
Therapy Area/IndicationsAutism Spectrum DisorderDepressive Disorder, MajorBipolar Disorder +[28] 
Global Approved IndicationsDepressive Disorder, MajorBipolar Disorder
Approved Indications in ChinaDepressive Disorder, Major
Original Approved Country/TerritoryUnited States
Original Approved Date1961/04/07
Country/TerritoryCzechiaBelgiumCanada +[14] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAlgoTherapeutixNational Center For Complementary And Integrative HealthUniversity Of Michigan +[6] 
Inactive CompaniesUtah State UniversityDong Wha Pharm Co LtdUlm University +[11] 
Active IndicationsDepressive Disorder, MajorHeadacheErythromelalgia +[7] 
Inactive IndicationsAutism Spectrum DisorderBipolar DisorderCompulsive Behavior +[21] 

Other Information

ATC CodeN06AA09
Related LinksWikipediaDrugBankKEGG